The Anti-hypothyroidism Regulating Role of Ficus carica L. Leaves Extract: In-vitro, In-vivo, and In-silico Studies

Document Type : Original Article


1 Pharmacognosy Department, National Research Centre (NRC), El Behouth St., P.O. 12622, Cairo, Egypt.

2 Therapeutic Chemistry Department, National Research Centre (NRC), 33 El Buhouth St., P.O. 12622, Cairo, Egypt.

3 Microbial Genetics Department, Biotechnology Research Institute, National Research Centre, Giza, Egypt.

4 Egypt Center for Research and Regenerative Medicine (ECRRM), Cairo, Egypt.


The study targets anti-hypothyroditic effect and phytochemistry of the Ficus carica L. leaves pet. ether extract. GC/MS data of the unsaponifiable fraction led to identification of 23 compounds (85.14%) while identified saponifiable fraction amounted 78.56%. TLC chromatography led to isolation of five triterpenes (α-amyrin, taraxerol, lupeol, 3, 22 dihydroxy-13 (18) oleanene and β- sitosterol). The extract exhibited promising in vitro anti-inflammatory response via fluorometric assay. The extract was orally given at a dose (500 mg/kg) where different biomarkers were measured in vivo: serum TSH, T3, T4, IL-6 and oxidative stress levels. Ficus carica pet. ether extract recorded amelioration in all parameters suggesting its significance against thyroid hypothyroidism induced in male rats as prophylaxis and treatment. Histological examinations of all the groups supported the results. Additionally, molecular docking studies reinforced the results, demonstrating that the major compounds exhibited high binding interactions with (COX-1), (5-LOX), (IL-6), and thyroid stimulating hormone receptor.


Main Subjects

Articles in Press, Accepted Manuscript
Available Online from 26 March 2024
  • Receive Date: 27 February 2024
  • Revise Date: 19 March 2024
  • Accept Date: 28 March 2024